No Detail Found!

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes.

Author(s)
Jing Li Binzhou People’s Hospital, Shandong, 256610, China.
Jinzhi Ji Department of Health Management Center, Binzhou People’s Hospital, Shandong, 256610, China.
Fuyan Liu Department of Operation Room, Binzhou People’s Hospital, Shandong, 256610, China.
Lingling Wang Binzhou People’s Hospital, Shandong, 256610, China.
Abstract
Objective: To investigate the clinical efficacy of insulin glargine combined with acarbose in the treatment of elderly patients with diabetes. Methods: One hundred and forty-four elderly patients with diabetes who received treatment between December 2016 and December 2017 in Binzhou People's Hospital, China, were selected and divided into a control group and an observation group, 72 each, using random number table. The control group was treated with insulin glargine, while the observation group was treated with insulin glargine combined with acarbose. The therapeutic effect, improvement of quality of life and adverse reactions were compared between the two groups. Results: After treatment, fasting blood glucose (FBG), 2h postprandial blood glucose (PBG) and glycosylated hemoglobin (Hb Alc) of the two groups were lower than those before treatment, and the decrease degree of the observation group was significantly larger than that of the control group (P0.05). Conclusion: The combination of insulin Glargine and Acarbose can significantly control the blood glucose level of elderly patients with diabetes, improve the biochemical indicators, and enhance the quality of life. It is worth promotion in clinical practice.
Publication Details
Page(s) 609-613
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 35, Issue: 3, Year: 2019

Request the full text from PASTIC

Keywords
Elderly diabetics, Acarbose, insulin glargine
0

Citations

0

Downloads

61

Views